Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy.

Authors

REKTOROVÁ Irena REKTOR Ivan BAREŠ Martin DOSTÁL V. EHLER Edvard FANFRDLOVÁ Zuzana FIEDLER J. KLAJBLOVÁ Hana KULIŠŤÁK P. RESSNER P. SVÁTOVÁ J. URBÁNEK Karel VELÍSKOVÁ J.

Year of publication 2005
Type Article in Periodical
Magazine / Source European Journal of Neurology
MU Faculty or unit

Faculty of Medicine

Citation
Field Neurology, neurosurgery, neurosciences
Keywords cognitive; depression; dopamine receptor a agonists; Parkinson's disease
Description Cognitive performance was studied in people with advanced Parkinson's disease and mild or moderate depression before and after 8 months of treatment with dopamine agonists (pramipexole and pergolige) in an add-on to L-dopa therapy. Both drugs were safe with regard to cognitive functioning in the studied group of patients.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info